Latest drug discovery Stories
Partnership will help the association expand its current managed-healthcare programs into quality readiness programs for clinical researchers. Austin, TX (PRWEB)
AGB101 could be the first drug to modify progression of amnestic mild cognitive impairment (aMCI) in patients at a high-risk for progressing to Alzheimer's dementia NEW YORK, Jan.
Phase 3-ready AGB101 designed to address aMCI, the pre-dementia stage of Alzheimer's Disease BALTIMORE, Jan.
Dramatically improving opportunities for patients to find the right clinical trial MOUNTAIN VIEW, California, January 27, 2015 /PRNewswire/ -- U.S.-based cancer
WEST HAVEN, Conn., Jan. 23, 2015 /PRNewswire/ -- NanoViricides, Inc.
LONDON and BOSTON, January 23, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted
DALLAS, January 23, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced
Selexis SA Is the First Biotechnology Company to Deliver Manufacturing-Ready Research Cell Banks with a Fully Sequenced Genome and Transcriptome Geneva, Switzerland